Ownership history in Walleye Capital LLC · 26 quarters on record
This page tracks every 13F SEC filing in which Walleye Capital LLC reported a position in CELLDEX THERAPEUTICS INC NEW (CLDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 5,900 | +2,900 | +96.7% | 0.00% | $153K | $25.87 |
| 2025 Q3 | REDUCED | 3,000 | -90,327 | -96.8% | 0.00% | $78K | $25.87 |
| 2025 Q1 | ADDED | 93,327 | +91,627 | +5389.8% | 0.01% | $1.7M | $18.15 |
| 2025 Q1 | REDUCED | 1,700 | -2,700 | -61.4% | 0.00% | $31K | $18.15 |
| 2024 Q2 | REDUCED | 4,400 | -45,783 | -91.2% | 0.00% | $163K | $37.01 |
| 2024 Q2 | ADDED | 50,183 | +41,083 | +451.5% | 0.00% | $1.9M | $37.01 |
| 2024 Q2 | ADDED | 9,100 | +7,600 | +506.7% | 0.00% | $337K | $37.01 |
| 2024 Q1 | REDUCED | 1,500 | -1,600 | -51.6% | 0.00% | $63K | $41.97 |
| 2024 Q1 | ADDED | 3,100 | +2,064 | +199.2% | 0.00% | $130K | $41.97 |
| 2024 Q1 | REDUCED | 1,036 | -168,232 | -99.4% | 0.00% | $43K | $41.97 |
As of 2025 Q4 — sorted by position size